Clarient Inc

Entity type image
Type: Company
Name: Clarient Inc
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial PR Newswire

/PRNewswire/ --$ Arno Therapeutics, Inc. (ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced new, positive data from three studies supporting its investigational compound onapristone ... [Published Yahoo! Finance - May 15 2013]
First reported May 14 2013 - Updated May 14 2013 - 1 reports

Genetic Testing Market Outlook to 2017

provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present ... [Published MarketResearch.com - May 14 2013]
First reported May 10 2013 - Updated May 10 2013 - 6 reports

Arno Therapeutics to Collaborate with Clarient for Development of Diagnostic Test

– Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that it has signed an agreement with Clarient Diagnostic Services, Inc., a GE Healthcare company, ... [Published FierceBiotech - May 10 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

General Electric Is Carrying Out Its Strategy Efficiently

General Electric (GE) is the largest conglomerate in the world, and currently the company has exposure to a number of sectors. A degree of diversification in operations can provide substantial security against the business risks. However, conglomerates ... [Published Seeking Alpha - May 08 2013]
First reported Apr 30 2013 - Updated May 01 2013 - 1 reports

MILITARY $120,000 Federal Contract Awarded to Clarient

Targeted News ServiceWASHINGTON, April 30 -- Clarient Inc., Aliso Viejo, Calif., won a $120,000 federal contract from the U.S. Navy's Bureau of Medicine and Surgery, San Diego, for pathology testing, diagnostics stains and laboratory testing services ... [Published Equities.com - Apr 30 2013]
First reported Apr 12 2013 - Updated Apr 12 2013 - 1 reports

GE Healthcare: Driving Growth Through Alliances And Acquisitions

GE Healthcare is a division of General Electric Company (GE) which provides medical technologies and services in order to provide more affordable healthcare with quality. GE Healthcare has a well-diversified portfolio which includes 3 verticals - Diagnostic ... [Published Seeking Alpha - Apr 12 2013]
First reported Feb 02 2013 - Updated Feb 03 2013 - 1 reports

General Electric and 3 Dow Giants with Market Moving News This Week

Here’s your Cheat Sheet to the week in Dow 30 stock news: Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now ! General Electric Company  ( NYSE:GE ): Current price $22.62 GE Capital, Healthcare ... [Published Wall St. Cheat Sheet - Feb 02 2013]
First reported Jan 31 2013 - Updated Jan 31 2013 - 1 reports

Clarient adopts Qiagen's therascreen KRAS RGQ PCR Kit as companion diagnostic for colorectal cancer

Clarient - a GE Healthcare Company and a leading provider of cancer laboratory testing services in the United States - has adopted the use of Qiagen's therascreen KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux ... [Published PharmaBiz - Jan 31 2013]
First reported Jan 30 2013 - Updated Jan 30 2013 - 1 reports

Disney Partners With Network18 Group and 2 Dow Movers to Follow

Cisco Systems  ( NASDAQ:CSCO ): Current price $20.66 Cisco is going for another acquisition, Cognitive Security, which is a Czech security software firm. The buyer intends to unite Cognitive’s tech with its own worldwide, cloud-based threat intelligence ... [Published Wall St. Cheat Sheet - Jan 30 2013]

Quotes

...to benefit from treatment in these difficult-to-treat diseases," said Glenn Mattes, chief executive officer and president, Arno Therapeutics. "These data add to the growing body of knowledge indicating the potential of the compound to fill a high unmet medical need and we plan to pursue a global orphan drug designation in endometrial cancer."
Glenn Mattes, Chief Executive Officer and President of Arno, stated: "Our collaboration with Clarient marks a significant milestone for Arno and the development of onapristone. Clarient's expertise and strength in cancer diagnostics makes them an ideal partner to help us continue our investigation of onapristone and move toward initiating a Phase I clinical study."
Commenting on the latest development, Olivier Loeillot, General Manager of Enterprise Solutions at GE Healthcare said : "Vaccines are vital in the fight against global disease and we're pleased to be working with Bio-Manguinhos/Fiocruz on this important project. GE Healthcare's global capabilities and industry-leading expertise in biopharmaceutical manufacturing technologies, coupled with iBio's innovative technology and experience in plant-based protein expression, provide a solid foundation for this design project. By working closely with the team at Bio-Manguinhos/Fiocruz we will together design a state-of-the-art, technologically-advanced facility that's ready to meet the vaccine needs of tomorrow."
...Helge Lubenow, senior vice president, Molecular Diagnostics Business Area and member of the Executive Committee of Qiagen. "The future of Personalized Healthcare will be shaped by standardized tests like the therascreen KRAS test, backed by scientific rigor and regulatory review. Our growing portfolio of innovative diagnostics and efficient automation platforms is making healthcare more effective, saving money for payers and improving life for patients."

More Content

All (23) | News (14) | Reports (3) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Arno Therapeutics to Present Positive, New Data... [Published Yahoo! Finance - May 15 2013]
Genetic Testing Market Outlook to 2017 [Published MarketResearch.com - May 14 2013]
Arno Therapeutics to Collaborate with Clarient ... [Published FierceBiotech - May 10 2013]
Arno Therapeutics to Collaborate With Clarient,... [Published BioSpace - May 10 2013]
Arno Therapeutics to Collaborate With Clarient ... [Published Equities.com - May 10 2013]
Arno Therapeutics to Collaborate With Clarient ... [Published Yahoo! Finance - May 10 2013]
Arno Therapeutics to Collaborate With Clarient ... [Published GlobeNewswire: Acquisitions News - May 10 2013]
Arno Therapeutics to Collaborate With Clarient ... [Published Morningstar.com - May 10 2013]
Arno Therapeutics to Collaborate With Clarient ... [Published Nasdaq - May 10 2013]
General Electric Is Carrying Out Its Strategy E... [Published Seeking Alpha - May 08 2013]
Molecular Diagnostics in Cancer Testing Report:... [Published Individual.com - Apr 30 2013]
MILITARY $120,000 Federal Contract Awarded to C... [Published Equities.com - Apr 30 2013]
GE Healthcare: Driving Growth Through Alliances... [Published Seeking Alpha - Apr 12 2013]
GE Healthcare Launches its First “Next-Generati... [Published Business Wire Science: Science News - Apr 08 2013]
GE Healthcare Launches its First “Next-Generati... [Published Business Wire Health News - Apr 08 2013]
N-of-One Named One of Boston’s Hottest Healthca... [Published Yahoo! Finance - Mar 28 2013]
N-of-One, Inc. Partners with Fox Chase Cancer C... [Published Yahoo! Finance - Feb 21 2013]
Global IVD (In Vitro Diagnostics) Procedure Vol... [Published PRWeb - Feb 07 2013]
General Electric and 3 Dow Giants with Market M... [Published Wall St. Cheat Sheet - Feb 02 2013]
Clarient adopts Qiagen's therascreen KRAS RGQ P... [Published PharmaBiz - Jan 31 2013]
Disney Partners With Network18 Group and 2 Dow ... [Published Wall St. Cheat Sheet - Jan 30 2013]
QIAGEN's KRAS Companion Diagnostic for Colorect... [Published Financial Services - Jan 30 2013]
This Is It! BBQ and Seafood Host Breast Cancer ... [Published PRWeb - Oct 19 2012]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
General Electric and 3 Dow Giants with Market M... [Published Wall St. Cheat Sheet - Feb 02 2013]
Here’s your Cheat Sheet to the week in Dow 30 stock news: Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now ! General Electric Company  ( NYSE:GE ): Current price $22.62 GE Capital, Healthcare ...
Disney Partners With Network18 Group and 2 Dow ... [Published Wall St. Cheat Sheet - Jan 30 2013]
Cisco Systems  ( NASDAQ:CSCO ): Current price $20.66 Cisco is going for another acquisition, Cognitive Security, which is a Czech security software firm. The buyer intends to unite Cognitive’s tech with its own worldwide, cloud-based threat intelligence ...
1

Press Releases

sort by: Date | Relevance
Arno Therapeutics to Collaborate With Clarient ... [Published GlobeNewswire: Acquisitions News - May 10 2013]
GE Healthcare Launches its First “Next-Generati... [Published Business Wire Science: Science News - Apr 08 2013]
GE Healthcare Launches its First “Next-Generati... [Published Business Wire Health News - Apr 08 2013]
QIAGEN's KRAS Companion Diagnostic for Colorect... [Published Financial Services - Jan 30 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.